| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/19/2022 | 12.99% | Piper Sandler | $2.5 → $4 | Maintains | Neutral |
| 08/10/2022 | -43.5% | Roth Capital | → $2 | Downgrades | Buy → Neutral |
| 06/24/2022 | — | JP Morgan | Initiates Coverage On | → Neutral | |
| 05/25/2022 | -29.38% | Piper Sandler | → $2.5 | Initiates Coverage On | → Neutral |
| 08/06/2021 | 521.47% | Roth Capital | $25 → $22 | Maintains | Buy |
| 08/06/2021 | 634.46% | Oppenheimer | $25 → $26 | Maintains | Outperform |
| 08/06/2021 | 747.46% | HC Wainwright & Co. | $35 → $30 | Maintains | Buy |
| 06/01/2021 | 464.97% | HSBC | → $20 | Initiates Coverage On | → Buy |
| 03/03/2021 | 832.2% | Roth Capital | $20 → $33 | Maintains | Buy |
| 03/03/2021 | 888.7% | HC Wainwright & Co. | $11 → $35 | Maintains | Buy |
| 02/26/2021 | 464.97% | Roth Capital | → $20 | Initiates Coverage On | → Buy |
| 01/06/2021 | 154.24% | Cowen & Co. | → $9 | Upgrades | Market Perform → Outperform |
| 11/25/2020 | 41.24% | Cowen & Co. | → $5 | Initiates Coverage On | → Market Perform |
| 11/25/2020 | -5.37% | Jefferies | → $3.35 | Initiates Coverage On | → Buy |
| 12/12/2019 | 125.99% | Oppenheimer | → $8 | Initiates Coverage On | → Outperform |
| 03/20/2018 | 182.49% | B. Riley Securities | $8 → $10 | Maintains | Buy |
Amyris Questions & Answers
The latest price target for Amyris (NASDAQ: AMRS) was reported by Piper Sandler on September 19, 2022. The analyst firm set a price target for $4.00 expecting AMRS to rise to within 12 months (a possible 12.99% upside). 4 analyst firms have reported ratings in the last year.
The latest analyst rating for Amyris (NASDAQ: AMRS) was provided by Piper Sandler, and Amyris maintained their neutral rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Amyris, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Amyris was filed on September 19, 2022 so you should expect the next rating to be made available sometime around September 19, 2023.
While ratings are subjective and will change, the latest Amyris (AMRS) rating was a maintained with a price target of $2.50 to $4.00. The current price Amyris (AMRS) is trading at is $3.54, which is within the analyst's predicted range.